pmc logo imageJournal ListSearchpmc logo image
Logo of vhriskmanJournal URL: redirect3.cgi?&&auth=0FiMDatqEt8L19VBSjG4Id3ShzrCjd5u2kbybJAZj&reftype=publisher&issue-id=163093&journal-id=391&FROM=TOC|Banner&TO=Publisher|Other|N%2FA&rendering-type=normal&&http://dovepress.com/articles.php?journal_id=69
Other Issues:  previous | next | latest | archive
Volume 3(4);  August 2007
Review
PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive study
Erland Erdmann, John Dormandy, Robert Wilcox, Massimo Massi-Benedetti, and Bernard Charbonnel
Vasc Health Risk Manag. 2007 August; 3(4): 355–370.
PMCID: PMC2291341
Original Research
Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy
Roland Asmar, Juan Garcia-Puig, Philippe Gosse, Yuri A Karpov, Peter Wilhem De Leeuw, Dieter Magometschniggs, Lajos Matos, and Roland Schmieder
Vasc Health Risk Manag. 2007 August; 3(4): 371–380.
PMCID: PMC2291338
Arterial Stiffness and Pharmacological Interventions – The TRanscend Arterial stiffNess Substudy (TRANS study)
Jirar Topouchian, Ramzi El Feghali, Bruno Pannier, Shuyu Wang, Feng Zhao, Karel Smetana, Koon Teo, and Roland Asmar
Vasc Health Risk Manag. 2007 August; 3(4): 381–388.
PMCID: PMC2291337
Validation of four automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension
Jalil Belghazi, Ramzi N El Feghali, Thérèse Moussalem, Maya Rejdych, and Roland G Asmar
Vasc Health Risk Manag. 2007 August; 3(4): 389–400.
PMCID: PMC2291343
Effect of continuous cisternal cerebrospinal fluid drainage for patients with thin subarachnoid hemorrhage
Yasunari Otawara, Kuniaki Ogasawara, Yoshitaka Kubo, Masayuki Sasoh, and Akira Ogawa
Vasc Health Risk Manag. 2007 August; 3(4): 401–404.
PMCID: PMC2291329
Increased tissue factor, MMP-8, and D-dimer expression in diabetic patients with unstable advanced carotid atherosclerosis
Jerzy Krupinski, Marta M Turu, M Angels Font, Nesser Ahmed, Matthew Sullivan, Ana Luque, Francisco Rubio, Lina Badimon, and Mark Slevin
Vasc Health Risk Manag. 2007 August; 3(4): 405–412.
PMCID: PMC2291344
Occipital lobe infarctions are different
Halvor Naess, Ulrikke Waje-Andreassen, and Lars Thomassen
Vasc Health Risk Manag. 2007 August; 3(4): 413–415.
PMCID: PMC2291333
Combined use of brain natriuretic peptide and C-reactive protein for predicting cardiovascular risk in outpatients with type 2 diabetes mellitus
Toshihiro Tsuruda, Johji Kato, Takahiro Sumi, Kazuya Mishima, Hiroyuki Masuyama, Hiroyuki Nakao, Takuroh Imamura, Tanenao Eto, and Kazuo Kitamura
Vasc Health Risk Manag. 2007 August; 3(4): 417–423.
PMCID: PMC2291340
Reviews
Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction
Naylin Bissessor and Harvey White
Vasc Health Risk Manag. 2007 August; 3(4): 425–430.
PMCID: PMC2291334
Bisoprolol in the treatment of chronic heart failure
Pascal de Groote, Pierre-Vladimir Ennezat, and Fréderic Mouquet
Vasc Health Risk Manag. 2007 August; 3(4): 431–439.
PMCID: PMC2291328
Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions
Alaide Chieffo, Tiziana Claudia Aranzulla, and Antonio Colombo
Vasc Health Risk Manag. 2007 August; 3(4): 441–451.
PMCID: PMC2291332
Managing hypertension in diabetic patients – focus on trandolapril/verapamil combination
Sanjib Kumar Sharma, Piero Ruggenenti, and Giuseppe Remuzzi
Vasc Health Risk Manag. 2007 August; 3(4): 453–465.
PMCID: PMC2291330
Prolonged-release nicotinic acid for the management of dyslipidemia: an update including results from the NAUTILUS study
Anja Vogt, Ursula Kassner, Ulrike Hostalek, and Elisabeth Steinhagen-Thiessen
Vasc Health Risk Manag. 2007 August; 3(4): 467–479.
PMCID: PMC2291331
Update on stents: Recent studies on the TAXUS® stent system in small vessels
Shuzou Tanimoto, Joost Daemen, and Patrick W Serruys
Vasc Health Risk Manag. 2007 August; 3(4): 481–490.
PMCID: PMC2291327
Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease
Sven-Olof Olofsson, Olov Wiklund, and Jan Borén
Vasc Health Risk Manag. 2007 August; 3(4): 491–502.
PMCID: PMC2291326
Treatment update: thiazolidinediones in combination with metformin for the treatment of type 2 diabetes
John M Stafford and Tom Elasy
Vasc Health Risk Manag. 2007 August; 3(4): 503–510.
PMCID: PMC2291335
The burden of type 2 diabetes: strategies to prevent or delay onset
Nayyar Iqbal
Vasc Health Risk Manag. 2007 August; 3(4): 511–520.
PMCID: PMC2291325
Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors
José Tuñón, José Luis Martín-Ventura, Luis Miguel Blanco-Colio, Nieves Tarín, and Jesús Egido
Vasc Health Risk Manag. 2007 August; 3(4): 521–526.
PMCID: PMC2291342
Factor eight inhibitor bypass activity (FEIBA) in the management of bleeds in hemophilia patients with high-titer inhibitors
Geir E Tjønnfjord and Pål Andre Holme
Vasc Health Risk Manag. 2007 August; 3(4): 527–531.
PMCID: PMC2291336
Systematic Review
Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients
Ana T Rocha, Edison F Paiva, Arnaldo Lichtenstein, Rodolfo Milani, Jr, Cyrillo Cavalheiro-Filho, and Francisco H Maffei
Vasc Health Risk Manag. 2007 August; 3(4): 533–553.
PMCID: PMC2291339
Other Issues:  previous | next | latest | archive